{"id":203763,"date":"2026-11-12T09:06:11","date_gmt":"2026-11-12T09:06:11","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/203763\/"},"modified":"2026-11-12T09:06:11","modified_gmt":"2026-11-12T09:06:11","slug":"eli-lilly-becomes-first-drugmaker-to-have-a-glp-1-weight-loss-pill-approved-in-china-consumer","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/203763\/","title":{"rendered":"Eli Lilly becomes first drugmaker to have a GLP-1 weight loss pill approved in China | Consumer"},"content":{"rendered":"<p>By Andrew Silver<\/p>\n<p>SHANGHAI, Nov 12 (Reuters) &#8211; Eli Lilly on Thursday became the first company to have a GLP-1 weight-loss pill approved in China, gaining a leg up on Danish rival Novo Nordisk in the\u00a0world&#8217;s second-largest pharmaceutical market.<\/p>\n<p>The pill, orforglipron, will compete for market share in China with Lilly&#8217;s own once-weekly GLP-1 weight-loss injection as well as with similar injections from Novo, Pfizer, and local \u200cfirm Innovent Biologics.<\/p>\n<p>Novo and Lilly believe weight-loss pills could \u00e2\u0080\u008battract patients reluctant to use injections. Novo has also submitted an application to sell the oral version of Wegovy in China.<\/p>\n<p>Oral therapies account for about a third of US obesity prescriptions following the rollout of Novo&#8217;s Wegovy pill in January this year, according to Novo presentations in September.<\/p>\n<p>China&#8217;s \u00e2\u0080\u008bNational Health Commission has said the proportion of overweight or obese people \u00e2\u0081\u00a0in the country could reach more than 65% by 2030, up from roughly 50% in 2020.<\/p>\n<p>Annual sales of GLP-1 therapies for weight management in China could reach 30 billion yuan ($4.5 billion) in the next five to seven years, up from an estimated 3 billion yuan to 4 billion yuan at present, Yang Huang, J.P. Morgan&#8217;s head of China healthcare research, has forecast.<\/p>\n<p>Lilly did not immediately respond to a request for comment on\u00a0how it will price orforglipron in China or when it would be available.\u00a0<\/p>\n<p>(Reporting by Andrew Silver; additional reporting from Beijing newsroom; Editing by Christian Schmollinger and Edwina Gibbs)<\/p>\n","protected":false},"excerpt":{"rendered":"By Andrew Silver SHANGHAI, Nov 12 (Reuters) &#8211; Eli Lilly on Thursday became the first company to have&hellip;\n","protected":false},"author":2,"featured_media":203764,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[3336,47492,38,272],"class_list":["post-203763","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-consumer","tag-nation-world","tag-news","tag-novo-nordisk"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/117602679967948815","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/203763","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=203763"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/203763\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/203764"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=203763"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=203763"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=203763"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}